Literature DB >> 17927959

Hypoxia suppresses astrocyte glutamate transport independently of amyloid formation.

Hannah E Boycott1, Mark Dallas, John P Boyle, Hugh A Pearson, Chris Peers.   

Abstract

Sustained hypoxia alters the expression of numerous proteins and predisposes individuals to Alzheimer's disease (AD). We have previously shown that hypoxia in vitro alters Ca2+ homeostasis in astrocytes and promotes increased production of amyloid beta peptides (Abeta) of AD. Indeed, alteration of Ca2+ homeostasis requires amyloid formation. Here, we show that electrogenic glutamate uptake by astrocytes is suppressed by hypoxia (1% O2, 24h) in a manner that is independent of amyloid beta peptide formation. Thus, hypoxic suppression of glutamate uptake and expression levels of glutamate transporter proteins EAAT1 and EAAT2 were not mimicked by exogenous application of amyloid beta peptide, or by prevention of endogenous amyloid peptide formation (using inhibitors of either beta or gamma secretase). Thus, dysfunction in glutamate homeostasis in hypoxic conditions is independent of Abeta production, but will likely contribute to neuronal damage and death associated with AD following hypoxic events.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17927959     DOI: 10.1016/j.bbrc.2007.09.102

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

Review 1.  Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders.

Authors:  Berislav V Zlokovic
Journal:  Nat Rev Neurosci       Date:  2011-11-03       Impact factor: 34.870

2.  Caveolin-1 Sensitivity of Excitatory Amino Acid Transporters EAAT1, EAAT2, EAAT3, and EAAT4.

Authors:  Abeer Abousaab; Jamshed Warsi; Bernat Elvira; Florian Lang
Journal:  J Membr Biol       Date:  2015-12-21       Impact factor: 1.843

3.  Age-related severity of focal ischemia in female rats is associated with impaired astrocyte function.

Authors:  Danielle K Lewis; Kristen T Thomas; Amutha Selvamani; Farida Sohrabji
Journal:  Neurobiol Aging       Date:  2011-12-10       Impact factor: 4.673

Review 4.  Targeting astrocytes for stroke therapy.

Authors:  Yanxin Zhao; David A Rempe
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

Review 5.  Death by a thousand cuts in Alzheimer's disease: hypoxia--the prodrome.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2013-02-12       Impact factor: 3.911

6.  Down-Regulation of Excitatory Amino Acid Transporters EAAT1 and EAAT2 by the Kinases SPAK and OSR1.

Authors:  Abeer Abousaab; Jamshed Warsi; Bernat Elvira; Ioana Alesutan; Zohreh Hoseinzadeh; Florian Lang
Journal:  J Membr Biol       Date:  2015-08-02       Impact factor: 1.843

7.  Fatty acid biosynthesis from glutamate and glutamine is specifically induced in neuronal cells under hypoxia.

Authors:  Stephen A Brose; Amanda L Marquardt; Mikhail Y Golovko
Journal:  J Neurochem       Date:  2013-12-17       Impact factor: 5.372

8.  TRPA1-FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3p.

Authors:  Jonathan Berrout; Eleni Kyriakopoulou; Lavanya Moparthi; Alexandra S Hogea; Liza Berrout; Cristina Ivan; Mihaela Lorger; John Boyle; Chris Peers; Stephen Muench; Jacobo Elies Gomez; Xin Hu; Carolyn Hurst; Thomas Hall; Sujanitha Umamaheswaran; Laura Wesley; Mihai Gagea; Michael Shires; Iain Manfield; Margaret A Knowles; Simon Davies; Klaus Suhling; Yurema Teijeiro Gonzalez; Neil Carragher; Kenneth Macleod; N Joan Abbott; George A Calin; Nikita Gamper; Peter M Zygmunt; Zahra Timsah
Journal:  Nat Commun       Date:  2017-10-16       Impact factor: 14.919

9.  Cholinergic Hypofunction in Presbycusis-Related Tinnitus With Cognitive Function Impairment: Emerging Hypotheses.

Authors:  Qingwei Ruan; Zhuowei Yu; Weibin Zhang; Jian Ruan; Chunhui Liu; Ruxin Zhang
Journal:  Front Aging Neurosci       Date:  2018-04-06       Impact factor: 5.750

10.  What are the links between hypoxia and Alzheimer's disease?

Authors:  Rahul Lall; Raihan Mohammed; Utkarsh Ojha
Journal:  Neuropsychiatr Dis Treat       Date:  2019-05-21       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.